Agranulocytosis due to metamizole, is it time to restrict its prescription?

• Raquel Cobos Campos,
• Sainza García de Andoin Fernández,
• Iraida Pérez Llanos,
• Cristina Bermúdez-Ampudia,
• Antxon Apiñaniz Fernández de Larrinoa

Affiliations

Raquel Cobos Campos

Primary care, epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz

Sainza García de Andoin Fernández

Primary care, epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz

Iraida Pérez Llanos

Primary care, epidemiology and Public Health Group, Bioaraba Health Research Institute, Vitoria-Gasteiz

Cristina Bermúdez-Ampudia

Osakidetza Basque Health Service, Vitoria-Gasteiz

Antxon Apiñaniz Fernández de Larrinoa

Department of Preventive Medicine and Public Health, University of the Basque Country, Vitoria-Gasteiz